Protagenic Therapeutics Potential Upside
| PTIX Stock | | | USD 0.79 0.21 36.21% |
Potential Upside is the amount of upward price movement an investor or an analyst expects of a particular equity instrument. Below is Protagenic Therapeutics's current Potential Upside with peer comparisons and related risk metrics.
Current Potential Upside Value
The Potential Upside of 28.95 for Protagenic Therapeutics indicates significant estimated upside from current levels. Protagenic Therapeutics's current price is well below the model-derived fair value estimate, though large gaps may also reflect model uncertainty.
Potential Upside | = | 1PM2PM |
| = | 28.95 | |
| 1PM | = | First upper moment |
| 2PM | = | Second upper moment |
Potential Upside Peers Comparison
Relative to peers, Protagenic Therapeutics's Potential Upside is above the group average of 20.75. Peer readings range from 5.31 (Revelation Biosciences) to 58.18 (Lipella Pharmaceuticals Common), reflecting wide dispersion across the sector. Protagenic Therapeutics shows greater estimated upside from current levels than the peer average.
Potential Upside Relative To Other Indicators
The chart below plots Potential Upside against Maximum Drawdown for Protagenic Therapeutics and its peers. Each point represents one equity — position along the horizontal axis shows Potential Upside while the vertical axis shows Maximum Drawdown. Equities that cluster in different quadrants carry distinct risk-return profiles. Use the dropdowns to swap in other indicators for either axis.
Protagenic Therapeutics's Maximum Drawdown of
60.30 runs about
2.08 times its Potential Upside of
28.95 . This indicates Maximum Drawdown is significantly higher than Potential Upside for Protagenic Therapeutics.
Methodology, Assumptions & Data Sources
Protagenic Therapeutics' Potential Upside currently stands at 28.95. This Potential Upside reading for Protagenic Therapeutics results from applying the indicator's calculation rules to price and volume data over the selected window. Price data is sourced from standardized end-of-day feeds across supported exchanges, normalized for corporate actions. Protagenic Therapeutics operates in the health care sector, which may exhibit distinct volatility and momentum characteristics relative to the broader market. Results are based on historical returns and do not predict future performance. This indicator is provided for informational purposes.
Other Technical Indicators